Building partnerships that advance precision neurology.
Neurological diseases remain among the greatest challenges in medicine, requiring new biological insights and new approaches to understanding disease.
CircRNA and the CircPath™ Platform provide a broader view of disease biology, creating new opportunities for biomarker discovery, translational research, and therapeutic development.
We collaborate with researchers, academic institutions, biopharma, foundations, and industry partners to help shape the future of precision neurology.
Advance understanding of disease biology through collaborative research, biomarker validation, publication generation, and exploration of novel applications of circRNA biology.
Support biomarker development, patient stratification,therapeutic development, and clinical research through circRNA-enabledmolecular insight.
Collaborateon platform expansion, technology integration, co-development initiatives, andnew applications of molecular intelligence.
Generatenew biological insights through deeply characterized cohorts, longitudinaldatasets, and real-world research populations.
We collaborate with leading academic institutions, research organizations, foundations, and industry partners to advance the science of brain-derived circRNA and precision neurology.
Progress in brain health requires collaboration across academia, biotechnology, pharmaceutical development, and clinical research. Whether you are exploring novel biomarkers, investigating disease biology, advancing therapeutic research, or developing new technologies, we welcome opportunities to collaborate and help shape the future of precision neurology.